Loading...
PhD Marko Anderluh

PhD Marko Anderluh
no.: 21456 source: ARIS

researcher – active in research organisation
Phone number 01 476 95 00
E-mail marko.anderluhat signffa.uni-lj.si
Foreign language skills
Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   
Keywords
Peptidomimetics, fibrinogen receptor antagonists, molecular basis of medicinal chemistry
Bibliography Representative bibliographic units | Personal| COBISS+
source: COBISS
source: SICRIS
Points
1,078.39
A''
134.86
A'
365.95
A1/2
606.44
CI10
1,210
CImax
116
h10
19
A1
3.61
A3
4.29
Data for the last 5 years (citations for the last 10 years) on March 4, 2024; A3 for period 2018-2022 (update for tender in 2023: YES)
Data for ARIS tenders ( 12.01.2024 – Project tender, archive )
Database Linked records Citations Pure citations Average pure citations
WoS 94  1,618  1,349  14.35 
Scopus 95  1,703  1,442  15.18 
Mentoring junior researchers
source: ARIS
no. Name and surname Type Period Code
1 Edvin Purić  Bologna doctoral studies    55895 
2 PhD Matjaž Weiss  Bologna doctoral studies  10/1/2017 - 9/30/2022  50503 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
    Pharmacy  SI University of Ljubljana, Faculty of Pharmacy 2000 
Doctor's degree  Ph. D.   Pharmacy  SI University of Ljubljana, Faculty of Pharmacy 2004 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Title ecris.org.employ_rolegroup
Full time employment (120%, RD:20%)  University of Ljubljana, Faculty of Pharmacy  Chair for Pharmaceutical Chemistry  11/1/2000  Research assistant  Full professor  Researcher 
Research projects Legend
source: ARIS
ARIS research and infrastructure programmes Legend
source: ARIS
International projects
no. Code Title Period Head No. of publications
1. HORIZON-GlyCanDrug-101119601  GlyCanDrug - A training network on the design of precision therapeutics that target key glycan motifs implicated in cancer   12/1/2023 - 11/30/2027  Marko Anderluh   
2. HORIZON-PROTAG-8  PROTAG-8 - Protein degraders for targeting galectin-8   12/1/2023 - 11/30/2027  Marko Anderluh   
3. COST-CA18103 - INNOGLY    11/13/2018 - 10/7/2023     
4. COST-CA18132 GLYCONanoPROBES  Functional Glyconanomaterials for the Development of Diagnostics and Targeted Therapeutic Probes   1/1/2018 - 12/31/2022  Marko Anderluh   
5. H2020-PhD4GlycoDrug-211719  Multidisciplinary European Joint Doctorate in the Design and Developmen of Glyco Drugs   1/1/2017 - 12/31/2021  Marko Anderluh   
Views history
Favourite